A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab
Immunotherapy is an effective new approach in the treatment of many malignancies. However, pancreatic ductal adenocarcinoma (PDAC) does not usually respond to immunotherapy. We discuss the case of a patient with metastatic microsatellite instability-high PDAC who had a prolonged response to single-agent pembrolizumab for almost 3 years.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab ; volume:14 ; number:3 ; year:2021 ; pages:1414-1417 ; extent:4
Case reports in oncology ; 14, Heft 3 (2021), 1414-1417 (gesamt 4)
- Creator
-
Guedikian, Annie A.
Randall, Megan E.
Sharko, Anita
Leslie, William T.
- DOI
-
10.1159/000519181
- URN
-
urn:nbn:de:101:1-2022011223451625098518
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guedikian, Annie A.
- Randall, Megan E.
- Sharko, Anita
- Leslie, William T.
Other Objects (12)
Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report
A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report
Pembrolizumab
Immunogenicity of pembrolizumab in patients with advanced tumors
Complete Response to Pembrolizumab in a Patient with Castration-Resistant Prostate Cancer with Both BRCA Positivity and a High Frequency of Microsatellite Instability: A Case Report
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
Medullary colon carcinoma with microsatellite instability: case report
SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers
Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report
A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report
Pembrolizumab
Immunogenicity of pembrolizumab in patients with advanced tumors
Complete Response to Pembrolizumab in a Patient with Castration-Resistant Prostate Cancer with Both BRCA Positivity and a High Frequency of Microsatellite Instability: A Case Report
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
Medullary colon carcinoma with microsatellite instability: case report
SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers
Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report
A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report
Pembrolizumab
Immunogenicity of pembrolizumab in patients with advanced tumors
Complete Response to Pembrolizumab in a Patient with Castration-Resistant Prostate Cancer with Both BRCA Positivity and a High Frequency of Microsatellite Instability: A Case Report
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
Medullary colon carcinoma with microsatellite instability: case report